Sun Yanrong, who has attended many press conferences on the prevention and control of martial lung, was investigated

Sun Yanrong, the deputy director of the Biological Center of China’s Ministry of Science and Technology, who was involved in the development of a drug to combat Wuhan pneumonia, is under disciplinary review and supervisory investigation by the authorities for allegedly “serious violations of discipline and law”. Sun Yanrong, who has repeatedly attended press conferences on the prevention and control of Wuhan pneumonia, has not been seen on the Internet search engine since the April 15 press conference.

The website of the State Supervisory Commission of the Central Discipline Inspection Commission of the Communist Party of China (CPC) released the news last night (24) without explaining why Sun Yanrong was being investigated, except that she was under disciplinary examination by the Discipline Inspection and Supervision Group of the State Supervision Commission of the CPC in the Ministry of Science and Technology and supervisory investigation by the Hebei Provincial Supervisory Commission.

After the outbreak of the epidemic in China, Sun Yanrong repeatedly attended the State Council’s joint prevention and control mechanism press conferences to speak on the effectiveness of drugs for the treatment of Wulong, for example, she cited data in March that chloroquine phosphate has become a clinical drug for treatment, with no significant adverse reactions; in mid-April, she even reported that China is carrying out four clinical drugs, and more than 10 results were included in the treatment and diagnosis program. But since the beginning of the Valley has not been her updated news appeared.

Now 47 years old, Sun Yanrong has 25 years of party experience and is a medical doctor and researcher. In 2007, she became the deputy director of the Medical Biotechnology Division of the China Biotechnology Development Center, and in 2011, she joined the Ministry of Science and Technology, rising four levels from deputy researcher to deputy director of the China Biotechnology Development Center in six years.

According to the website of China Center for Biotechnology Development, the Center was established at the end of 1983 and is directly under the Ministry of Science and Technology. The Center is responsible for conducting strategic research and policy analysis in the field of biotechnology in China, participating in the formulation of science and technology plans, undertaking the management of biological resources and biosafety, and promoting international exchanges.